| Bioactivity | DLCI-1 is a potent and selective oral inhibitor of cytochrome P450 2A6 (CYP2A6) that markedly reduces nicotine self-administration in both male and female mice. |
| CAS | 2244569-14-8 |
| Formula | C12H14N2S |
| Molar Mass | 218.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
DLCI-1
CAS: 2244569-14-8 F: C12H14N2S W: 218.32
DLCI-1 is a potent and selective oral inhibitor of cytochrome P450 2A6 (CYP2A6) that markedly reduces nicotine self-admi
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.